The company is a high-tech service enterprise centered on third-party medical testing and pathological diagnosis services. Through its accumulated core resource advantages such as “big platform, big network, big service, big sample and big data”, it is committed to providing leading medical diagnostic information integration services to medical institutions at all levels across the country. The core entrepreneurial team of Jinyu Medical has been actively exploring the operating model of medical testing outsourcing services in China since the 90s of the last century, pioneering the domestic third-party medical testing industry. After years of development, it has now become a market-leading enterprise in the domestic third-party medical testing industry. The company's main business is in key disease fields such as clinical specialties, hematological diseases, neurological and clinical immune diseases, and solid tumors. Physico-chemical mass spectrometry, genomic testing, pathological diagnosis, biochemiluminescence testing, immunological testing, other comprehensive tests, etc. Corporate honors: won the “2018 Responsible Brand Award” at the 8th China Charity Festival; won the “2018 Social Responsibility · Health, Public Welfare and Poverty Alleviation Contribution Award” in the “2018 New Express - New Backbone · New Dynamics” event; won the “China County Hospital Most Influential Discipline Co-Construction Award” at the 2019 China Health County Conference.
No Data